Login / Signup

Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway, and Finland.

Nicklas VinterOlli HalminenMika LehtoK E Juhani AiraksinenTomas AnderssonPer WändellMartin HolzmannOle-Christian RutherfordSigrun HalvorsenPia CordsenLars FrostSøren Paaske Johnsen
Published in: Basic & clinical pharmacology & toxicology (2023)
In OAC-naïve patients with incident AF, persistence of OAC therapy and clinical outcomes vary across Denmark, Sweden, Norway, and Finland Initiation of real-time efforts are warranted to ensure uniform high-quality care across nations and regions.
Keyphrases
  • atrial fibrillation
  • healthcare
  • cardiovascular disease
  • quality improvement
  • stem cells
  • mesenchymal stem cells
  • chronic pain
  • replacement therapy